At Cosmo, we are committed to improve peoples lives by developing products that address unmet medical needs in the fields of gastroenterology, dermatology and healthtech.
Products
The Company has 6 approved drugs in its portfolio and 2 approved medical devices. Cosmo has successfully identified unmet medical needs, managed the product development process and obtained regulatory approval for its products. We license our approved products to partners with strong marketing and sales expertise.
Find out moreInvestors
Latest News
Cosmo Pharmaceuticals Delivers Record 2024 Results – Completes Phase III Enrollment for Androgenetic Alopecia in males – Proposes increased dividend of €2.05 per share – reinforcing Shareholder Value and Growth Momentum into 2025
Read MoreCosmo Appoints Andrea Cherubini as Chief AI Officer to Drive AI Expansion Across Portfolio
Read MoreUpcoming Events
Share price
More informationsTherapeutic Focus
Cosmo’s therapeutic focus is on the treatment of gastrointestinal diseases (including IBD, colonic infections and colorectal cancer – CRC), increase the effectiveness of endoscopic examinations and to treat persistent skin conditions, like acne, and androgenetic alopecia, that have a long-term physical and emotional impact on lives and self-esteem.
Find out more
Our Mission
To improve people’s lives by developing products that address unmet medical needs in the fields of gastroenterology, dermatology and healthtech.
Find out more
Manufacturing
We provide services related to the production of pharmaceutical products as: assessment of manufacturing processes, technology transfer, evaluation of pharmaceutical product stability, testing and release to the market and drafting of the necessary documentation for pharmaceutical products’ registration.
Find out more